Prevalence and Causes of Stigmatization Among Patients With Chronic Skin Diseases in Saudi Arabia.

Autor:	Alblowi YH; Department of Emergency Medicine, King Khaled Hospital, Ministry of Health, Tabuk, SAU., Alsaati AA; Department of Dermatology, College of Medicine, King Faisal University, Al-Hofuf, SAU., Alzubaidi AS; Department of Medicine and Surgery, College of Medicine, Umm Al-Qura University, Al-Qunfudhah, SAU., Alsifri SS; Department of Dermatology, Faculty of Medicine, King Abdulaziz University, Jeddah, SAU., AlHarthi Y; Department of Dermatology and Dermatologic Surgery, Prince Sultan Military Medical City, Ministry of Defence, Riyadh, SAU., Alotaibi MK; Department of Medicine, Unaizah College of Medicine and Medical Sciences, Qassim University, Unaizah, SAU.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2024 Apr 30; Vol. 16 (4), pp. e59373. Date of Electronic Publication: 2024 Apr 30 (Print Publication: 2024).
DOI:	10.7759/cureus.59373
Abstrakt:	Background: Skin diseases can lead to stigmatization with negative consequences for patients' quality of life and mental health. Aim: The aim of this study was to estimate the prevalence of stigmatization experienced by patients with vitiligo, psoriasis, acne, rosacea, or atopic dermatitis and to assess the relationships between the level of stigmatization and patient characteristics. Methods: This cross-sectional study included adult patients with vitiligo, psoriasis, acne, rosacea, or atopic dermatitis attending the dermatology clinics of various general hospitals in Saudi Arabia. Stigma levels were assessed using the six-item Stigma Scale. Results: The prevalence of stigmatization was 90.4% among the 280 patients included. Multiple regression analyses revealed the factors that independently and significantly increased the level of stigmatization. These included male gender (B = 4.300, 95%CI 3.407-5.192, P <0.001), positive family history of skin conditions (B = 2.267, 95%CI 1.139-3.395, P <0.001), number of skin diseases (B = 2.357, 95%CI 0.998-3.716, P = 0.001), and presence of facial lesions (B = 2.455, 95%CI 1.206-3.705, P<0.001). Conclusions: The prevalence of stigmatization is high among patients with chronic skin diseases in Saudi Arabia. Identifying patients at risk for high levels of stigmatization may allow them to be provided with appropriate social and psychological support. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Alblowi et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu